Maxime Samson Selected Research

Peripheral Nervous System Diseases (PNS Diseases)

1/2021	Significance of PR3-ANCA positivity in eosinophilic granulomatosis with polyangiitis (Churg-Strauss).
7/2016	Etiologies and prognostic factors of leukocytoclastic vasculitis with skin involvement: A retrospective study in 112 patients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Maxime Samson Research Topics

Disease

19	Giant Cell Arteritis (Horton Disease) 04/2024 - 05/2013
14	Vasculitis (Vasculitides) 12/2023 - 10/2013
10	Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis 11/2023 - 01/2018
8	Granulomatosis with Polyangiitis (Wegener's Granulomatosis) 11/2023 - 01/2018
8	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 06/2020 - 10/2011
7	Churg-Strauss Syndrome (Allergic Angiitis) 12/2023 - 09/2014
5	Asthma (Bronchial Asthma) 12/2023 - 01/2016
5	Autoimmune Diseases (Autoimmune Disease) 08/2023 - 10/2011
5	Microscopic Polyangiitis 12/2020 - 09/2014
4	Infections 12/2023 - 01/2021
3	Pathologic Constriction (Stenosis) 11/2023 - 01/2022
3	Inflammation (Inflammations) 01/2023 - 08/2012
3	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2022 - 06/2015
3	Thrombosis (Thrombus) 01/2018 - 07/2016
2	VEXAS syndrome 12/2023 - 01/2023
2	Eosinophilia 12/2023 - 06/2013
2	Neoplasms (Cancer) 10/2023 - 09/2011
2	Vascular Remodeling 01/2023 - 10/2012
2	Hyperplasia 05/2022 - 10/2011
2	Infarction (Infarctions) 02/2022 - 01/2021
2	COVID-19 01/2022 - 12/2021
2	Peripheral Nervous System Diseases (PNS Diseases) 01/2021 - 07/2016
2	Polyarteritis Nodosa (Periarteritis Nodosa) 12/2020 - 09/2014
1	Necrosis 12/2023
1	Neointima 11/2023
1	Disease Progression 11/2023
1	Renal Insufficiency (Renal Failure) 11/2023
1	Uveitis 10/2023
1	Histiocytosis 10/2023
1	Autoimmune Hemolytic Anemia (Cold Agglutinin Disease) 08/2023
1	Pulmonary Fibrosis (Fibrosing Alveolitis) 01/2023
1	Cryoglobulinemia 04/2022
1	Connective Tissue Diseases (Connective Tissue Disease) 02/2022
1	Meningitis 01/2022
1	Obesity 12/2021
1	Systemic Vasculitis 12/2021
1	Polymyalgia Rheumatica (Rhizomelic Pseudopolyarthritis) 12/2021
1	Hypercholesterolemia 01/2021
1	Ileus 01/2021
1	Leukemia 01/2021
1	Melena 01/2021
1	Neutropenia 01/2021
1	Bronchitis 01/2021
1	Pyelonephritis 01/2021
1	Septic Shock (Toxic Shock Syndrome) 01/2021
1	Thrombocytopenia (Thrombopenia) 01/2021

Drug/Important Bio-Agent (IBA)

15	GlucocorticoidsIBA 12/2023 - 05/2013
14	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 12/2023 - 10/2013
12	Rituximab (Mabthera)FDA Link 11/2023 - 10/2011
8	Inosine Triphosphate (ITP)IBA 06/2020 - 10/2011
7	AntibodiesIBA 08/2023 - 06/2013
6	Prednisone (Sone)FDA LinkGeneric 12/2023 - 01/2016
5	tocilizumab (atlizumab)FDA Link 01/2022 - 08/2012
3	CytokinesIBA 11/2023 - 08/2012
3	Adrenal Cortex Hormones (Corticosteroids)IBA 10/2023 - 09/2014
3	Interleukin-6 (Interleukin 6)IBA 05/2022 - 08/2012
3	Immunosuppressive Agents (Immunosuppressants)IBA 12/2020 - 09/2014
2	Methylprednisolone FDA LinkGeneric 12/2023 - 09/2023
2	EnzymesIBA 12/2023 - 01/2023
2	CreatinineIBA 11/2023 - 01/2022
2	Prednisolone (Predate)FDA LinkGeneric 01/2022 - 12/2021
2	SteroidsIBA 01/2022 - 01/2016
2	Hemoglobins (Hemoglobin)IBA 01/2021 - 11/2018
2	Ustekinumab (CNTO 1275)FDA Link 01/2021 - 01/2018
2	Peroxidase (Myeloperoxidase)IBA 12/2020 - 06/2013
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 04/2024
1	Janus Kinase InhibitorsIBA 12/2023
1	Azacitidine (5 Azacytidine)FDA Link 12/2023
1	dupilumabIBA 12/2023
1	benralizumabIBA 12/2023
1	ChemokinesIBA 11/2023
1	DesminIBA 11/2023
1	Reactive Oxygen Species (Oxygen Radicals)IBA 11/2023
1	Oxidants (Oxidizing Agents)IBA 11/2023
1	Azathioprine (Imuran)FDA LinkGeneric 11/2023
1	NeopterinIBA 10/2023
1	acceleratory factor from growth hormone (AcG)IBA 09/2023
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 08/2023
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2023
1	Interleukin-17 (Interleukin 17)IBA 05/2022
1	Endothelin-1 (Endothelin 1)IBA 05/2022
1	Extracellular Matrix ProteinsIBA 05/2022
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 05/2022
1	belimumabIBA 04/2022
1	Alkylating AgentsIBA 04/2022
1	Antinuclear AntibodiesIBA 02/2022
1	mepolizumabIBA 01/2022
1	Methotrexate (Mexate)FDA LinkGeneric 01/2022
1	ORALIT (ORS)IBA 12/2021
1	Oxygen (Dioxygen)IBA 12/2021
1	Transaminases (Aminotransferases)IBA 01/2021
1	Morphine (MS Contin)FDA LinkGeneric 01/2021
1	Cholesterol Ester Transfer ProteinsIBA 09/2020

Therapy/Procedure

18	Therapeutics 11/2023 - 09/2014
2	Salvage Therapy 11/2023 - 01/2022
2	Remission Induction 10/2020 - 01/2020
2	Biological Therapy 10/2020 - 01/2018
1	Cell- and Tissue-Based Therapy (Cell Therapy) 01/2023
1	Drug Tapering 01/2021
1	Aftercare (After-Treatment) 01/2021